These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
489 related articles for article (PubMed ID: 18557406)
41. Medical devices; medical device reporting. Direct final rule. Food and Drug Administration, HHS Fed Regist; 2005 Feb; 70(38):9516-28. PubMed ID: 15736310 [TBL] [Abstract][Full Text] [Related]
42. User reporting of medical device related incidents. Sievänen H Med Device Technol; 2003 May; 14(4):26-9. PubMed ID: 12774575 [TBL] [Abstract][Full Text] [Related]
43. [Exploration on the regulation mode of medical device quality and safety on a life-circle basis]. Yu HL; Qian XS Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Mar; 30(2):120-2, 133. PubMed ID: 16830806 [TBL] [Abstract][Full Text] [Related]
44. The Food and Drug Administration's regulation of risk disclosure for implantable cardioverter defibrillators: has technology outpaced the Agency's regulatory framework? Basile EM; Lorell BH Food Drug Law J; 2006; 61(2):251-72. PubMed ID: 16903031 [No Abstract] [Full Text] [Related]
45. Scope of the European Medical Device Directives. Donawa M Med Device Technol; 2008; 19(1):32, 34-5. PubMed ID: 18348437 [TBL] [Abstract][Full Text] [Related]
46. The FDA's humanitarian device exemption program. Eydelman MB; Chen EA Health Aff (Millwood); 2011 Jun; 30(6):1210-2; author reply 1212. PubMed ID: 21653975 [No Abstract] [Full Text] [Related]
47. Medical device regulation for manufacturers. McAllister P; Jeswiet J Proc Inst Mech Eng H; 2003; 217(6):459-67. PubMed ID: 14702983 [TBL] [Abstract][Full Text] [Related]
48. [Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?]. Stordeur S; Vinck I; Neyt M; Van Brabandt H; Hulstaert F Rev Epidemiol Sante Publique; 2013 Apr; 61(2):105-10. PubMed ID: 23477881 [TBL] [Abstract][Full Text] [Related]
49. [Standards used in the regulation of medical device in USA]. Hu W; Gu H Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Nov; 21(11):1263-7. PubMed ID: 18069490 [TBL] [Abstract][Full Text] [Related]
50. New trends in biological evaluation of medical devices. Bollen LS Med Device Technol; 2005 Jun; 16(5):10-5. PubMed ID: 15984539 [TBL] [Abstract][Full Text] [Related]
51. New US agent requirements. Donawa M Med Device Technol; 2002; 13(1):35-7. PubMed ID: 11921780 [TBL] [Abstract][Full Text] [Related]
52. Testing for technical files: avoiding too little and too much. Clifford A Med Device Technol; 1998 Sep; 9(7):30-1. PubMed ID: 10186981 [TBL] [Abstract][Full Text] [Related]
53. [Importance of the Therapeutic Products Act for the ENT practitioner]. Kaiser R; Ininger G; Stosslein E HNO; 2003 Jun; 51(6):513-24; quiz 525-6. PubMed ID: 12858855 [TBL] [Abstract][Full Text] [Related]
54. Risk management of European device clinical studies. Donawa M Med Device Technol; 2007; 18(2):39-42. PubMed ID: 17494500 [TBL] [Abstract][Full Text] [Related]
55. Switzerland: one year's experience with new regulations and a new agency. Voelksen R Med Device Technol; 2003 Mar; 14(2):28-9. PubMed ID: 12698697 [TBL] [Abstract][Full Text] [Related]
56. New efforts to harmonise clinical evaluation. Donawa M Med Device Technol; 2006; 17(9):28, 30, 32. PubMed ID: 17240684 [TBL] [Abstract][Full Text] [Related]
57. Foreign Establishment Registration and United States agent requirements. Nolte CJ; McNamara-Cullinane M Med Device Technol; 2002 Dec; 13(10):32-3. PubMed ID: 12575528 [TBL] [Abstract][Full Text] [Related]
58. Old customs, ancient lore: the development of custom device law through neglect. Klepinski RJ Food Drug Law J; 2006; 61(2):237-49. PubMed ID: 16903030 [No Abstract] [Full Text] [Related]
59. The Italian industry: meeting today's challenges. Galavotti P Med Device Technol; 2008; 19(3):52-3. PubMed ID: 18557411 [No Abstract] [Full Text] [Related]